OverviewSuggest Edit

Calcivis is a dental biologic and device manufacturer. It focuses on the treatment of tooth decay and enabling preventive dentistry. The company provides an imaging system that allows dental practitioners to offer evidence-based preventive treatment for dental caries patients.
HQEdinburgh, GB

Latest Updates

Employees (est.) (Sept 2021)7(-12%)
Revenue (FY, 2018)£12.2 K(-98%)
Cybersecurity ratingBMore

Key People/Management at Calcivis

Adam Christie

Adam Christie

Bruce Vernon

Bruce Vernon

Show more

Calcivis Office Locations

Calcivis has offices in Edinburgh and Boston
Edinburgh, GB (HQ)
9 Little France Rd
Boston, MA, US
One Marina Park Drive Suite 1410
Show all (2)

Calcivis Financials and Metrics

Summary Metrics

Founding Date


Calcivis total Funding

$22.3 m

Calcivis latest funding size

$5.48 m

Time since last funding

2 years ago

Calcivis investors

Calcivis's latest funding round in September 2019 was reported to be $5.5 m. In total, Calcivis has raised $22.3 m
Show all financial metrics

Calcivis Revenue

Calcivis's revenue was reported to be £12.16 k in FY, 2018

Revenue (FY, 2018)


Gross profit (FY, 2018)


Gross profit margin (FY, 2018), %


Net income (FY, 2018)


EBIT (FY, 2018)


Cash (31-Oct-2018)

GBPFY, 2015FY, 2016FY, 2018



Cost of goods sold


Gross profit


Gross profit Margin, %

GBPFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018



Accounts Receivable




Current Assets

GBPFY, 2015FY, 2016FY, 2017FY, 2018

Cash From Operating Activities


Cash From Investing Activities


Cash From Financing Activities


Net Change in Cash

GBPFY, 2014

Financial Leverage

1.2 x
Show all financial metrics

Calcivis Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Calcivis Online and Social Media Presence

Embed Graph

Calcivis Blogs

Scottish dental tech firm prepares to take on fight against tooth decay

As dentists worldwide begin to tackle the backlog of patients whose tooth decay may have worsened during the Covid-19 pandemic*, Edinburgh-based dental technology company, Calcivis, is preparing for a US launch with a restructuring of its board and the successful completion of its latest funding rou…

Publication of Calcivis Imaging System pivotal clinical study

Calcivis announces the publication of two key clinical and scientific papers in the journal, Clinical and Experimental Dental Research. Both are available via Open Access on the Wiley Online Library, using the links below. The pivotal clinical study was designed in consultation with the FDA, to supp…

CALCiViS receives Approvable Letter for its unique CALCiViS® Imaging System from US FDA

CALCiViS System, developed to enable and drive the adoption of preventive dentistry – enables real-time visualisation of active tooth decay   Edinburgh, March 5th 2020 – CALCiViS, a medical devices company focused on modernising the management of tooth decay and enabling preventive dentistry, announ…

An update on caries prevention

Fluoride varnish applications are usually targeted at children with a high risk of caries, or where it is considered beneficial to complement the fluoride found in water, from dietary sources and toothpaste. The preventive effect of fluoride varnish has been the subject of numerous studies conducted…

Focus on caries prevention

There is overwhelming evidence and agreement that fluoride is safe and highly effective for the prevention of tooth decay.[i] There are a range of fluoride modalities in the modern day that help to reduce the prevalence and severity of dental caries. These include individual use at home, through flu…

The effective management of erosive tooth wear

Dental erosion is a widespread condition with prevalence rates that appear to have increased in recent decades, particularly in young adults.[1] Currently, it is the third most commonly observed oral condition after caries and periodontal disease and is drawing increased attention as a risk factor f…
Show more

Calcivis Frequently Asked Questions

  • When was Calcivis founded?

    Calcivis was founded in 2012.

  • Who are Calcivis key executives?

    Calcivis's key executives are Adam Christie and Bruce Vernon.

  • How many employees does Calcivis have?

    Calcivis has 7 employees.

  • What is Calcivis revenue?

    Latest Calcivis annual revenue is £12.2 k.

  • What is Calcivis revenue per employee?

    Latest Calcivis revenue per employee is £1.7 k.

  • Who are Calcivis competitors?

    Competitors of Calcivis include BoneProx, GLO Science and Medical High Technologies.

  • Where is Calcivis headquarters?

    Calcivis headquarters is located at 9 Little France Rd, Edinburgh.

  • Where are Calcivis offices?

    Calcivis has offices in Edinburgh and Boston.

  • How many offices does Calcivis have?

    Calcivis has 2 offices.